Director Dealing 27 May
27 May 2010
The Company was informed on 27 May 2010 that FDS Pharma
Associates and its related parties disposed of 190,266 ordinary
shares of 0.5p each ("Ordinary Shares") at 9.78 pence each on 29
December 2009.
Following these disposals FDS Pharma Associates and its related
parties have an interest in Lipoxen of 41,965,050 Ordinary Shares,
representing 24.41 per cent of the issued Ordinary Share capital in
the Company.
For further information, please contact:
Enquiries:
|
Lipoxen plc
|
+44 (0)20 7389 5015
|
|
M. Scott Maguire, Chief Executive Officer
|
|
|
|
|
|
Singer Capital Markets (nominated adviser)
|
+44 (0)20 3205 7500
|
|
Jeff Keating / Claes Spång
|
|
|
|
|
|
Buchanan Communications
|
+44 (0)20 7466 5000
|
|
Lisa Baderoon, Catherine Breen
|
|